Perioperative Circulating Tumor Cells (CTCs), MCTCs, and CTC-White Blood Cells Detected by a Size-Based Platform Predict Prognosis in Renal Cell Carcinoma
Table 1
Relationship of perioperative total CTCs, mesenchymal CTC, CTC-WBC, and clinical characteristics. CTCs: circulating tumor cells; WBC: white blood cells; TNM: tumor, node, metastasis; : case number; : statistical value.
Clinical parameters
Total CTC
Mesenchymal CTC
CTC-WBC
Presurgery
Postsurgery
Presurgery
Postsurgery
Presurgery
Postsurgery
Negative
Positive
Negative
Positive
Negative
Positive
Negative
Positive
Age
<50
32
13
19
17
15
9
23
13
19
28
4
29
3
≥50
99
45
54
55
44
42
57
41
58
88
11
85
14
0.633
0.81
0.149
0.937
0.76
0.762
Sex
Male
83
35
48
44
39
37
46
30
53
70
13
69
14
Female
48
23
25
28
20
14
34
24
24
46
2
45
3
0.523
0.555
0.081
0.121
0.051
0.107
Pathological subtypes
Clear-cell carcinoma
113
52
61
60
53
47
66
45
68
100
13
98
15
Others
18
6
12
12
6
4
14
9
9
16
2
16
2
0.314
0.283
0.11
0.41
1
1
Differentiation
Low
22
7
15
13
9
7
15
11
11
19
3
21
1
Middle
102
48
54
57
45
41
61
42
60
92
10
88
14
High
7
3
4
2
5
3
4
1
6
5
2
5
2
0.446
0.38
0.79
0.29
0.248
0.189
TNM stage
T1
112
52
60
63
49
43
69
45
67
99
13
97
15
T2
15
4
11
6
9
5
10
6
9
13
2
13
2
T3
4
2
2
3
1
3
1
3
1
4
0
4
0
0.327
0.39
0.37
0.45
0.811
1
Types of surgery
Nephron-sparing surgery
79
35
44
51
28
27
52
34
45
68
11
68
11
Radical excision
52
23
29
21
31
24
28
20
32
48
4
46
6
0.993
0.007
0.16
0.60
0.273
0.691
Renal score
Low risk
28
12
16
17
11
7
21
13
15
24
4
24
4
Middle risk
72
32
40
42
30
31
41
32
40
63
9
66
6
High risk
31
14
17
13
18
13
18
9
22
29
2
24
7
0.983
0.243
0.23
0.28
0.576
0.126
Fluorescence microscopy images show three types of CTCs with positive expression of epithelial markers (EpCAM and CK8/18/19, red dots), biphenotypic markers (red dots and green dots), and mesenchymal markers (Vimentin and Twist, green dots). CTC-WBC was characterized as DAPI + CD45 + epithelial + and/or mesenchymal+. . EMT: epithelial-mesenchymal transition; CTC: circulating tumor cells; WBC: white blood cell; ISH: in situ hybridization.